U.S. FDA expectations and experiences when inspecting Indian drug and API manufacturers.

• In: D17 - Good Manufacturing Practices - Expectations for the coming decade (part I) on Thursday, 8 September 2011, 09:00-12:00
• At: Hyderabad (India) (2011)
• Type: Presentation
• By: ROSS, Bruce (U.S. Food and Drug Administration, Delhi, India)
• Abstract:

  This talk will cover some of the expectations for a pharmaceutical GMP or pre-approval inspection conducted by the U.S. Food and Drug Administration, covering common citations and issues identified  while providing the audience with some solutions and areas that improvements might be made at the firm to reduce findings or a 483-issuance.
  
  Presenting

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login